| Effectiveness of injectable extended-release naltrexone vs daily buprenorphine-naloxone for opioid dependence: a randomized clinical noninferiority trial L Tanum, KK Solli, JŠ Benth, A Opheim, K Sharma-Haase, P Krajci, ... JAMA psychiatry 74 (12), 1197-1205, 2017 | 271 | 2017 |
| Sustained‐release naltrexone for opioid dependence P Lobmaier, H Kornor, N Kunoe, A Bjørndal Cochrane Database of Systematic Reviews, 2008 | 146 | 2008 |
| Drug screening of hair by liquid chromatography-tandem mass spectrometry S Hegstad, HZ Khiabani, L Kristoffersen, N Kunøe, PP Lobmaier, ... Journal of Analytical Toxicology 32 (5), 364-372, 2008 | 115 | 2008 |
| Naltrexone implants after in-patient treatment for opioid dependence: randomised controlled trial N Kun, P Lobmaier, JK Vederhus, S Hegstad, M Gossop, Ø Kristensen, ... The British journal of psychiatry 194 (6), 541-546, 2009 | 107 | 2009 |
| Naltrexone depot formulations for opioid and alcohol dependence: a systematic review PP Lobmaier, N Kunøe, M Gossop, H Waal CNS neuroscience & therapeutics 17 (6), 629-636, 2011 | 97 | 2011 |
| Naltrexone implants compared to methadone: outcomes six months after prison release PP Lobmaier, N Kunøe, M Gossop, T Katevoll, H Waal European addiction research 16 (3), 139-145, 2010 | 92 | 2010 |
| Injectable and implantable sustained release naltrexone in the treatment of opioid addiction N Kunøe, P Lobmaier, H Ngo, G Hulse British journal of clinical pharmacology 77 (2), 264-271, 2014 | 53 | 2014 |
| Anxiety, depression, and insomnia among adults with opioid dependence treated with extended-release naltrexone vs buprenorphine-naloxone: a randomized clinical trial and follow … JŠ Benth, KK Solli, A Opheim, N Kunoe, P Krajci, K Sharma-Haase, ... JAMA psychiatry 76 (2), 127-134, 2019 | 45 | 2019 |
| Anxiety, depression, and insomnia among adults with opioid dependence treated with extended-release naltrexone vs buprenorphine-naloxone: a randomized clinical trial and follow … JŠ Benth, KK Solli, A Opheim, N Kunoe, P Krajci, K Sharma-Haase, ... JAMA psychiatry 76 (2), 127-134, 2019 | 45 | 2019 |
| Plasma concentrations during naltrexone implant treatment of opiate‐dependent patients L Olsen, AS Christophersen, G Frogopsahl, H Waal, J Mørland British journal of clinical pharmacology 58 (2), 219-222, 2004 | 45 | 2004 |
| Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX) N Kunøe, A Opheim, KK Solli, Z Gaulen, K Sharma-Haase, ZH Latif, ... BMC Pharmacology and Toxicology 17, 1-10, 2016 | 37 | 2016 |
| Challenges to antagonist blockade during sustained‐release naltrexone treatment N Kunøe, P Lobmaier, JK Vederhus, B Hjerkinn, M Gossop, S Hegstad, ... Addiction 105 (9), 1633-1639, 2010 | 37 | 2010 |
| Treatment research in prison: Problems and solutions in a randomized trial PP Lobmaier, N Kunøe, H Waal Addiction Research & Theory 18 (1), 1-13, 2010 | 33 | 2010 |
| The Norwegian offender mental health and addiction study–design and implementation of a national survey and prospective cohort study A Bukten, IO Lund, EB Rognli, MR Stavseth, P Lobmaier, S Skurtveit, ... Substance Abuse: Research and Treatment 9, SART. S23546, 2015 | 31 | 2015 |
| Retention in naltrexone implant treatment for opioid dependence N Kunøe, P Lobmaier, JK Vederhus, B Hjerkinn, S Hegstad, M Gossop, ... Drug and alcohol dependence 111 (1-2), 166-169, 2010 | 30 | 2010 |
| Effectiveness, safety and feasibility of extended‐release naltrexone for opioid dependence: a 9‐month follow‐up to a 3‐month randomized trial KK Solli, ZH Latif, A Opheim, P Krajci, K Sharma‐Haase, JŠ Benth, ... Addiction 113 (10), 1840-1849, 2018 | 29 | 2018 |
| No increased pain among opioid‐dependent individuals treated with extended‐release naltrexone or buprenorphine‐naloxone: a 3‐month randomized study and 9‐month open‐treatment … ZH Latif, KK Solli, A Opheim, N Kunoe, JŠ Benth, P Krajci, ... The American journal on addictions 28 (2), 77-85, 2019 | 22 | 2019 |
| No increased pain among opioid‐dependent individuals treated with extended‐release naltrexone or buprenorphine‐naloxone: a 3‐month randomized study and 9‐month open‐treatment … ZH Latif, KK Solli, A Opheim, N Kunoe, JŠ Benth, P Krajci, ... The American journal on addictions 28 (2), 77-85, 2019 | 22 | 2019 |
| Rusmiddelbruk og helsesituasjon blant innsatte i norske fengsel A Bukten, MR Stavseth, S Skurtveit, N Kunøe, P Lobmaier, IO Lund, ... The Norwegian Centre for Addiction Research: rapport 2, 2016, 2016 | 16 | 2016 |
| Intact responses to non-drug rewards in long-term opioid maintenance treatment M Eikemo, PP Lobmaier, ML Pedersen, N Kunøe, AM Matziorinis, ... Neuropsychopharmacology 44 (8), 1456-1463, 2019 | 14 | 2019 |
Lars TanumAkershus University HospitalVerifisert e-postadresse på ahus.no
